Antibody-drug conjugate targeting folate receptor α: a new milestone in personalized medicine for high-grade serous ovarian cancer.

Autor: Gonzalez-Martin A; Medical Oncology Department, Cancer Center Clinica Universidad de Navarra, Madrid, Spain agonzalezma@unav.es.
Jazyk: angličtina
Zdroj: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2024 Aug 05; Vol. 34 (8), pp. 1126-1127. Date of Electronic Publication: 2024 Aug 05.
DOI: 10.1136/ijgc-2024-005861
Abstrakt: Competing Interests: Competing interests: None declared.
Databáze: MEDLINE